Publications
Research at the Leibniz Institute for Immunology focuses on the development of pioneering immune-cell therapies targeting cancer, autoimmune diseases, and chronic inflammation. While developments in this field are highly relevant within the medical community, they are also of great interest to the wider general public. The LIT has a comprehensive archive of international articles, publications, lectures, and online resources aimed at a variety of audiences. So, whoever you are, if you do not find what you are looking for, please do not hesitate to contact us.
Ritter U. In situ veritas: combining omics and multiplex imaging can facilitate the detection and characterization of cell-cell interactions in tissues. Front Med (Lausanne). 2023 10:1155057. doi:10.3389/fmed.2023.1155057. PMID: 37332762
Karrasch S, Mavioglu RN, Matits L, Gumpp AM, Mack M, Behnke A, Tumani V, Karabatsiakis A, Bongartz W, Kolassa IT. Randomized controlled trial investigating potential effects of relaxation on mitochondrial function in immune cells: A pilot experiment. Biol Psychol. 2023 Oct. 183:108656. doi:10.1016/j.biopsycho.2023.108656. PMID: 37544424
Bartneck J, Hartmann AK, Stein L, Arnold-Schild D, Klein M, Stassen M, Marini F, Pielenhofer J, Meiser SL, Langguth P, Mack M, Muth S, Probst HC, Schild H, Radsak MP. Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy. Front Immunol. 2023 14:1267866. doi:10.3389/fimmu.2023.1267866. PMID: 37849753
Babl N, Hofbauer J, Matos C, Voll F, Menevse AN, Rechenmacher M, Mair R, Beckhove P, Herr W, Siska PJ, Renner K, Kreutz M, Schnell A. Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model. Front Oncol. 2023 13:1107484. doi:10.3389/fonc.2023.1107484. PMID: 36776340
Heidegger S, Stritzke F, Dahl S, Dassler-Plenker J, Joachim L, Buschmann D, Fan K, Sauer CM, Ludwig N, Winter C, Enssle S, Li S, Perl M, Gorgens A, Haas T, Orberg ET, Gottert S, Wolfel C, Engleitner T, Cortes-Ciriano I, Rad R, Herr W, Giebel B, Ruland J, Bassermann F et al. Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy. Cell Rep Med. 2023 Sep 19. 4:101171. doi:10.1016/j.xcrm.2023.101171. PMID: 37657445
Kao YS, Mamareli P, Dhillon-LaBrooy A, Stuve P, Godoy GJ, Velasquez LN, Raker VK, Weidenthaler-Barth B, Boukhallouk F, Rampoldi F, Berod L, Sparwasser T. Targeting ACC1 in T cells ameliorates psoriatic skin inflammation. J Mol Med (Berl). 2023 Sep. 101:1153-1166. doi:10.1007/s00109-023-02349-w. PMID: 37594540
Gruber I, Koelbl O, Treutwein M, Zeman F, Herr W, Holler E, Edinger M, Wolff D. Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia. Ann Hematol. 2023 Aug. 102:2199-2211. doi:10.1007/s00277-023-05318-y. PMID: 37347269
Braun FK, Rothhammer-Hampl T, Lorenz J, Pohl S, Menevse AN, Vollmann-Zwerenz A, Bumes E, Buttner M, Zoubaa S, Proescholdt M, Schmidt NO, Hau P, Beckhove P, Winner B, Riemenschneider MJ. Scaffold-Based (Matrigel) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype. Cells. 2023 Jul 14. 12doi:10.3390/cells12141856. PMID: 37508520
Barden, M., Holzinger, A., Velas, L., Mezősi-Csaplár, M., Szöőr, A., Vereb, G., Schütz, G. J., Hombach, A. A., Abken, H., CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation. Frontiers Immunol., 14: 1110482 (2023) doi: 10.3389/fimmu.2023.1110482
Kallinger I, Rubenich DS, Gluszko A, Kulkarni A, Spanier G, Spoerl S, Taxis J, Poeck H, Szczepanski MJ, Ettl T, Reichert TE, Meier JK, Braganhol E, Ferris RL, Whiteside TL, Ludwig N. Tumor gene signatures that correlate with release of extracellular vesicles shape the immune landscape in head and neck squamous cell carcinoma. Clin Exp Immunol. 2023 Jul 5. 213:102-113. doi:10.1093/cei/uxad019. PMID: 36752300